# Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension

> **NCT00644007** · PHASE3 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 109 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** SK3530

## Key facts

- **NCT ID:** NCT00644007
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2013-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644007, "Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00644007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*